CMAH Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of CMAH monoclonal antibodies for research focused on cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMAH). CMAH monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CMAH plays a critical role in the biosynthesis of sialic acids, which are essential components in cell signaling, immune response, and pathogen recognition. The proper functioning of cytidine monophosphate-N-acetylneuraminic acid hydroxylase is fundamental for maintaining cellular interactions and modulating various physiological processes. Research has shown that CMAH dysfunction can lead to various pathological conditions, making it an important focus in scientific investigations. Understanding CMAH's molecular mechanisms and regulatory pathways can provide valuable insights into disease development and potential therapeutic strategies. Investigating CMAH expression patterns and interactions can reveal new perspectives in cell biology and disease progression. Recent studies have highlighted CMAH's significance in evolutionary biology and human disease susceptibility. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of CMAH's role in health and disease.